Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Oct;38(10):1213-7.
doi: 10.1007/BF00422371.

A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM

Affiliations

A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM

G Paolisso et al. Diabetologia. 1995 Oct.

Abstract

To assess the role of fasting plasma non-esterified fatty acids (NEFA) in the development of non-insulin-dependent diabetes mellitus (NIDDM), data were analysed from annual examinations of 190 non-diabetic Pima Indians. Glucose tolerance was measured by a 75-g oral glucose tolerance test, insulin action by a euglycaemic hyperinsulinaemic (40 mU x m-2 x min-1) clamp and in vitro lipolysis using isolated abdominal fat cells. After a mean follow-up period of 4.0 +/- 2.4 years (mean +/- SD), 47 subjects developed NIDDM. Risk factors for NIDDM were estimated by proportional-hazards analysis and risk ratios (RR) with 95% confidence intervals (95% CI) calculated at the 90th and 10th percentile of the predictor variables. A large average fat-cell volume was predictive of NIDDM (RR=2.4; 95% CI=1.2-4.8) independent of age, sex, percent body and body fat distribution. A high fasting plasma NEFA concentration was also a risk factor for NIDDM (RR=2.3; 95% CI=1.1-4.7) independent of sex, percent body fat, waist/thigh ratio, insulin-mediated glucose uptake and fasting triglyceride concentration. We conclude that large fat cells and the resulting increased plasma NEFA concentrations are risk factors for the development of NIDDM.

PubMed Disclaimer

References

    1. Clin Chem. 1973 May;19(5):476-82 - PubMed
    1. Am J Physiol. 1986 Sep;251(3 Pt 1):E306-10 - PubMed
    1. Metabolism. 1993 Jan;42(1):36-43 - PubMed
    1. J Clin Invest. 1983 Oct;72(4):1246-54 - PubMed
    1. J Clin Invest. 1983 Nov;72(5):1737-47 - PubMed

MeSH terms